Literature DB >> 7744176

Respiratory muscle strength during continuous ambulatory peritoneal dialysis (CAPD).

N M Siafakas1, T Argyrakopoulos, K Andreopoulos, G Tsoukalas, N Tzanakis, D Bouros.   

Abstract

The purpose of this study was to investigate the effect of chronic renal failure (CRF) and continuous ambulatory peritoneal dialysis (CAPD) on respiratory muscle function. Global respiratory muscle strength was assessed by measuring mouth pressures during maximum static inspiration (PIMAX) near residual volume (RV) and expiration (PEMAX) near total lung capacity (TLC), in 26 patients. Maximum pressures, spirometry and lung volumes were measured before dialysis, 4 h after the administration of 2 l of dialysate into the peritoneal cavity, and just after the next drainage. In addition, biochemical indices (urea, creatinine, sodium, potassium, calcium and phosphorus) and haematological indices (haemoglobin (Hb) and haematocrit (Hct)) were measured once before the treatment. The results showed that mean PIMAX and PEMAX were normal, with a very wide range between patients, before CAPD. However, seven patients (27%) showed a PIMAX of < 75% predicted (pred) and eight (31%) a PEMAX < 75% pred. Maximal pressures decreased significantly during CAPD and increased again after the drainage of fluid. Similarly, lung volumes were within the normal range before and decreased significantly during CAPD. The forced expiratory volume in one second to forced vital capacity (FEV1/FVC) ratio did not change. We conclude that respiratory muscle strength was preserved in the majority of the patients with chronic renal failure treated with CAPD. During CAPD, lung volumes and respiratory muscle function were decreased, demonstrating an effect of the abdominal cavity on the mechanics of the respiratory system. However, the decrease in the maximum pressures was less than 20%, indicating that CAPD is a safe procedure in patients without pre-existing pulmonary disease or uraemic pulmonary complications.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7744176     DOI: 10.1183/09031936.95.08010109

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  Impact of continuous positive airway pressure (CPAP) on the respiratory capacity of chronic kidney disease patients under hemodialysis treatment.

Authors:  Vivian Bertoni Xavier; Renata Spósito Roxo; Luiz Antônio Miorin; Vera Lúcia Dos Santos Alves; Yvoty Alves Dos Santos Sens
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

2.  Dyspnea and respiratory muscle strength in end-stage liver disease.

Authors:  Georgios Kaltsakas; Efstathios Antoniou; Anastasios F Palamidas; Sofia-Antiopi Gennimata; Panorea Paraskeva; Anastasios Smyrnis; Antonia Koutsoukou; Joseph Milic-Emili; Nickolaos G Koulouris
Journal:  World J Hepatol       Date:  2013-02-27

3.  Pulmonary function and exercise tolerance are related to disease severity in pre-dialytic patients with chronic kidney disease: a cross-sectional study.

Authors:  Ruiter de Souza Faria; Natália Fernandes; Júlio César Moraes Lovisi; Maycon de Moura Reboredo; Murilo Sérgio de Moura Marta; Bruno do Valle Pinheiro; Marcus Gomes Bastos
Journal:  BMC Nephrol       Date:  2013-09-04       Impact factor: 2.388

4.  Impact of hemodialysis on dyspnea and lung function in end stage kidney disease patients.

Authors:  Anastasios F Palamidas; Sofia-Antiopi Gennimata; Foteini Karakontaki; Georgios Kaltsakas; Ioannis Papantoniou; Antonia Koutsoukou; Joseph Milic-Emili; Demetrios V Vlahakos; Nikolaos G Koulouris
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.